David Windley
Stock Analyst at Jefferies
(3.60)
# 836
Out of 5,115 analysts
200
Total ratings
66.96%
Success rate
14.24%
Average return
Main Sectors:
Stocks Rated by David Windley
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| UNH UnitedHealth Group | Maintains: Buy | $418 → $340 | $286.93 | +18.50% | 28 | Jan 28, 2026 | |
| HUM Humana | Upgrades: Buy | $253 → $313 | $195.20 | +60.35% | 19 | Dec 5, 2025 | |
| DEO Diageo | Downgrades: Neutral | n/a | $92.80 | - | 1 | Dec 3, 2025 | |
| MEDP Medpace Holdings | Maintains: Hold | $400 → $450 | $582.48 | -22.74% | 6 | Sep 9, 2025 | |
| IQV IQVIA Holdings | Upgrades: Buy | $195 → $225 | $230.15 | -2.24% | 5 | Sep 9, 2025 | |
| ICLR ICON Public Limited Company | Downgrades: Hold | $220 → $175 | $180.25 | -2.91% | 15 | Sep 9, 2025 | |
| FTRE Fortrea Holdings | Maintains: Hold | $7 → $9.5 | $16.81 | -43.49% | 3 | Sep 9, 2025 | |
| CRL Charles River Laboratories International | Upgrades: Buy | $142 → $195 | $210.48 | -7.35% | 20 | Sep 9, 2025 | |
| STE STERIS | Initiates: Hold | $263 | $262.60 | +0.15% | 1 | May 29, 2025 | |
| SLQT SelectQuote | Initiates: Hold | $2.75 | $1.42 | +93.66% | 1 | May 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $64 → $61 | $43.32 | +40.81% | 28 | Apr 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underperform | $12 | $14.35 | -16.38% | 1 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $402 → $422 | $274.11 | +53.95% | 17 | Sep 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $354 → $297 | $179.59 | +65.38% | 23 | Jul 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $12 → $3.75 | $0.50 | +649.55% | 4 | May 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $602 → $604 | $345.74 | +74.70% | 1 | Apr 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $365 → $375 | $504.22 | -25.63% | 1 | Apr 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $15 → $16 | $18.12 | -14.46% | 3 | Mar 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $225 → $270 | $203.92 | +32.40% | 2 | Mar 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $14 → $16 | $8.79 | +76.34% | 3 | Mar 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $323 → $536 | $231.12 | +131.91% | 10 | Feb 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $39 → $29 | $15.58 | +86.14% | 2 | Nov 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $264 → $248 | $5.45 | +4,450.46% | 1 | Feb 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $0.92 | - | 5 | Oct 9, 2017 |
UnitedHealth Group
Jan 28, 2026
Maintains: Buy
Price Target: $418 → $340
Current: $286.93
Upside: +18.50%
Humana
Dec 5, 2025
Upgrades: Buy
Price Target: $253 → $313
Current: $195.20
Upside: +60.35%
Diageo
Dec 3, 2025
Downgrades: Neutral
Price Target: n/a
Current: $92.80
Upside: -
Medpace Holdings
Sep 9, 2025
Maintains: Hold
Price Target: $400 → $450
Current: $582.48
Upside: -22.74%
IQVIA Holdings
Sep 9, 2025
Upgrades: Buy
Price Target: $195 → $225
Current: $230.15
Upside: -2.24%
ICON Public Limited Company
Sep 9, 2025
Downgrades: Hold
Price Target: $220 → $175
Current: $180.25
Upside: -2.91%
Fortrea Holdings
Sep 9, 2025
Maintains: Hold
Price Target: $7 → $9.5
Current: $16.81
Upside: -43.49%
Charles River Laboratories International
Sep 9, 2025
Upgrades: Buy
Price Target: $142 → $195
Current: $210.48
Upside: -7.35%
STERIS
May 29, 2025
Initiates: Hold
Price Target: $263
Current: $262.60
Upside: +0.15%
SelectQuote
May 21, 2025
Initiates: Hold
Price Target: $2.75
Current: $1.42
Upside: +93.66%
Apr 29, 2025
Maintains: Hold
Price Target: $64 → $61
Current: $43.32
Upside: +40.81%
Dec 10, 2024
Initiates: Underperform
Price Target: $12
Current: $14.35
Upside: -16.38%
Sep 17, 2024
Maintains: Buy
Price Target: $402 → $422
Current: $274.11
Upside: +53.95%
Jul 24, 2024
Maintains: Hold
Price Target: $354 → $297
Current: $179.59
Upside: +65.38%
May 14, 2024
Downgrades: Hold
Price Target: $12 → $3.75
Current: $0.50
Upside: +649.55%
Apr 19, 2024
Maintains: Buy
Price Target: $602 → $604
Current: $345.74
Upside: +74.70%
Apr 19, 2024
Maintains: Hold
Price Target: $365 → $375
Current: $504.22
Upside: -25.63%
Mar 25, 2024
Upgrades: Buy
Price Target: $15 → $16
Current: $18.12
Upside: -14.46%
Mar 4, 2024
Maintains: Buy
Price Target: $225 → $270
Current: $203.92
Upside: +32.40%
Mar 1, 2024
Maintains: Hold
Price Target: $14 → $16
Current: $8.79
Upside: +76.34%
Feb 7, 2024
Upgrades: Buy
Price Target: $323 → $536
Current: $231.12
Upside: +131.91%
Nov 1, 2023
Downgrades: Hold
Price Target: $39 → $29
Current: $15.58
Upside: +86.14%
Feb 25, 2021
Maintains: Hold
Price Target: $264 → $248
Current: $5.45
Upside: +4,450.46%
Oct 9, 2017
Upgrades: Buy
Price Target: n/a
Current: $0.92
Upside: -